113 related articles for article (PubMed ID: 27515292)
1. In vivo behavior of MIL-100 nanoparticles at early times after intravenous administration.
Simon-Yarza T; Baati T; Neffati F; Njim L; Couvreur P; Serre C; Gref R; Najjar MF; Zakhama A; Horcajada P
Int J Pharm; 2016 Sep; 511(2):1042-7. PubMed ID: 27515292
[TBL] [Abstract][Full Text] [Related]
2. Nanocarriers and the delivered drug: effect interference due to intravenous administration.
Vlasova MA; Rytkönen J; Riikonen J; Tarasova OS; Mönkäre J; Kovalainen M; Närvänen A; Salonen J; Herzig KH; Lehto VP; Järvinen K
Eur J Pharm Sci; 2014 Oct; 63():96-102. PubMed ID: 24964293
[TBL] [Abstract][Full Text] [Related]
3. Quantification of fumaric acid in liver, spleen and urine by high-performance liquid chromatography coupled to photodiode-array detection.
Baati T; Horcajada P; Gref R; Couvreur P; Serre C
J Pharm Biomed Anal; 2011 Dec; 56(4):758-62. PubMed ID: 21820831
[TBL] [Abstract][Full Text] [Related]
4. Quantification of trimesic acid in liver, spleen and urine by high-performance liquid chromatography coupled to a photodiode-array detection.
Baati T; Horcajada P; Gref R; Couvreur P; Serre C
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(23):2311-4. PubMed ID: 21727049
[TBL] [Abstract][Full Text] [Related]
5. Understanding the colloidal stability of the mesoporous MIL-100(Fe) nanoparticles in physiological media.
Bellido E; Guillevic M; Hidalgo T; Santander-Ortega MJ; Serre C; Horcajada P
Langmuir; 2014 May; 30(20):5911-20. PubMed ID: 24801765
[TBL] [Abstract][Full Text] [Related]
6. In vitro biocompatibility of mesoporous metal (III; Fe, Al, Cr) trimesate MOF nanocarriers.
Grall R; Hidalgo T; Delic J; Garcia-Marquez A; Chevillard S; Horcajada P
J Mater Chem B; 2015 Nov; 3(42):8279-8292. PubMed ID: 32262883
[TBL] [Abstract][Full Text] [Related]
7. In vitro determination of the CYP 3A4 activity in rat hepatic microsomes by liquid-phase extraction and HPLC-photodiode array detection.
Baati T; Horcajada P; Gref R; Couvreur P; Serre C
J Pharmacol Toxicol Methods; 2012 Jul; 66(1):29-34. PubMed ID: 22643301
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic busulfan encapsulated in a metal organic framework nanocarrier: first in vivo results.
Simon-Yarza MT; Baati T; Paci A; Lesueur LL; Seck A; Chiper M; Gref R; Serre C; Couvreur P; Horcajada P
J Mater Chem B; 2016 Jan; 4(4):585-588. PubMed ID: 32262940
[TBL] [Abstract][Full Text] [Related]
9. Heparin-engineered mesoporous iron metal-organic framework nanoparticles: toward stealth drug nanocarriers.
Bellido E; Hidalgo T; Lozano MV; Guillevic M; Simón-Vázquez R; Santander-Ortega MJ; González-Fernández Á; Serre C; Alonso MJ; Horcajada P
Adv Healthc Mater; 2015 Jun; 4(8):1246-57. PubMed ID: 25771896
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of a PAMAM dendrimer nanocarrier functionalized by SRL peptide for targeted gene delivery to the brain.
Zarebkohan A; Najafi F; Moghimi HR; Hemmati M; Deevband MR; Kazemi B
Eur J Pharm Sci; 2015 Oct; 78():19-30. PubMed ID: 26118442
[TBL] [Abstract][Full Text] [Related]
11. In vivo risk evaluation of carbon-coated iron carbide nanoparticles based on short- and long-term exposure scenarios.
Herrmann IK; Beck-Schimmer B; Schumacher CM; Gschwind S; Kaech A; Ziegler U; Clavien PA; Günther D; Stark WJ; Graf R; Schlegel AA
Nanomedicine (Lond); 2016 Apr; 11(7):783-96. PubMed ID: 26979124
[TBL] [Abstract][Full Text] [Related]
12. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
13. Novel hydrophobin-coated docetaxel nanoparticles for intravenous delivery: in vitro characteristics and in vivo performance.
Fang G; Tang B; Liu Z; Gou J; Zhang Y; Xu H; Tang X
Eur J Pharm Sci; 2014 Aug; 60():1-9. PubMed ID: 24815943
[TBL] [Abstract][Full Text] [Related]
14. Quantification of tetramethyl-terephthalic acid in rat liver, spleen and urine matrices by liquid-liquid phase extraction and HPLC-photodiode array detection.
Baati T; Horcajada P; David O; Gref R; Couvreur P; Serre C
J Pharm Biomed Anal; 2012; 67-68():98-103. PubMed ID: 22608098
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and toxicity evaluation of sesbania mosaic virus nanoparticles in mice.
Vishnu Vardhan GP; Savithri HS; Murthy MR; Hema M
Arch Virol; 2016 Oct; 161(10):2673-81. PubMed ID: 27395369
[TBL] [Abstract][Full Text] [Related]
16. Host-guest interactions in Fe(III)-trimesate MOF nanoparticles loaded with doxorubicin.
Anand R; Borghi F; Manoli F; Manet I; Agostoni V; Reschiglian P; Gref R; Monti S
J Phys Chem B; 2014 Jul; 118(29):8532-9. PubMed ID: 24960194
[TBL] [Abstract][Full Text] [Related]
17. Adsorptive Separation of Acetylene from Light Hydrocarbons by Mesoporous Iron Trimesate MIL-100(Fe).
Yoon JW; Lee JS; Lee S; Cho KH; Hwang YK; Daturi M; Jun CH; Krishna R; Chang JS
Chemistry; 2015 Dec; 21(50):18431-8. PubMed ID: 26515022
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution and pharmacokinetics of uniform magnetite nanoparticles chemically modified with polyethylene glycol.
Ruiz A; Hernández Y; Cabal C; González E; Veintemillas-Verdaguer S; Martínez E; Morales MP
Nanoscale; 2013 Dec; 5(23):11400-8. PubMed ID: 23832394
[TBL] [Abstract][Full Text] [Related]
19. Herb-drug interactions between Scutellariae Radix and mefenamic acid: Simultaneous investigation of pharmacokinetics, anti-inflammatory effect and gastric damage in rats.
Fong SY; Wong YC; Xie C; Zuo Z
J Ethnopharmacol; 2015 Jul; 170():106-16. PubMed ID: 25980420
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo DFO-chelatable labile iron release profiles among commercially available intravenous iron nanoparticle formulations.
Pai AB; Pai MP; Meyer DE; Bales BC; Cotero VE; Zheng N; Jiang W
Regul Toxicol Pharmacol; 2018 Aug; 97():17-23. PubMed ID: 29857115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
